| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/23/2003 | EP1328272A1 Nf-kappa-b inhibitors |
| 07/23/2003 | EP1328268A1 Combination of catechin and quercetin for pharmaceutical or dietary use |
| 07/23/2003 | EP1328265A2 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions |
| 07/23/2003 | EP1328263A2 Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells |
| 07/23/2003 | EP1328260A2 Methods and products related to pulmonary delivery of polysaccharides |
| 07/23/2003 | EP1328254A2 Lipid formulations for target delivery |
| 07/23/2003 | EP1328242A2 Use of agents containing creatine, creatinine and/or derivatives thereof for strengthening and improving the structure of keratin fibers |
| 07/23/2003 | EP1254134B1 1,3-dihydro-2h-indol-2-one derivatives,and their use as ligands for v1b or v1b and v1a arginine-vasopressin-receptors |
| 07/23/2003 | EP1228073B1 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 07/23/2003 | EP1154785B1 Inhibitors for use in hemostasis and immune function |
| 07/23/2003 | EP1140199B1 Hyaluronate lyase used for promoting penetration in topical agents |
| 07/23/2003 | EP1140006B1 Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis |
| 07/23/2003 | EP1089753B1 Use of a dipeptide for stimulating repair processes |
| 07/23/2003 | EP1086096B1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
| 07/23/2003 | EP1077717B1 Use of lipopeptides or lipoproteins for wound treatment |
| 07/23/2003 | EP1073445B1 Substance mixture for topical application comprising olive oil and honey |
| 07/23/2003 | EP1032575B1 2,3-diaryl-pyrazolo(1,5-b)pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 07/23/2003 | EP0975636B1 1h-pyrazolo[3,4-d]pyrimidine-4,6-diones as t-cell proliferation inhibitors |
| 07/23/2003 | EP0951294B1 Method of producing concentrated non-buffered solutions of fibronectin |
| 07/23/2003 | EP0942724B1 Gel formulations for topical drug delivery |
| 07/23/2003 | EP0898559B1 Cytoprotective compounds |
| 07/23/2003 | EP0858319B1 Use of carboxylic acids having a sulphur function for promoting skin exfoliation or stimulating epidermal regeneration |
| 07/23/2003 | CN1432020A 嘌呤衍生物 Purine derivatives |
| 07/23/2003 | CN1432011A Benzoamide piperidine compounds as substance P antagonists |
| 07/23/2003 | CN1432007A Inhibitors of alpha L beta 2 mediated cell adhesion |
| 07/23/2003 | CN1431999A Indole derivatives with vascular damagine activity |
| 07/23/2003 | CN1431998A Growth hormone secretagogues |
| 07/23/2003 | CN1431941A 挤压模 Extrusion die |
| 07/23/2003 | CN1431911A Transgenically produced decorin |
| 07/23/2003 | CN1431904A Protease inhitors |
| 07/23/2003 | CN1431903A Minoxidil-containing preparations |
| 07/23/2003 | CN1431902A Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 07/23/2003 | CN1431900A Methods and compsns. useful in enhancing oxygon delivery to cells |
| 07/23/2003 | CN1431894A Cosmetic compsn. comprising human serum albumin obtained from transgenic non-human animals |
| 07/23/2003 | CN1431009A Medicine for curing wind dampness, injuries from falls and ulcer in opening of sore |
| 07/23/2003 | CN1431008A Medicine for treating various fungal skin disease or bromidrosis |
| 07/23/2003 | CN1431007A Combination of external remedy for treating skin disease and venereal disease |
| 07/23/2003 | CN1431006A Pilatory |
| 07/23/2003 | CN1430995A Formula for removing speckles as well as its preparing method |
| 07/23/2003 | CN1430986A Compound zedoary oil ointment and its preparing method |
| 07/23/2003 | CN1430972A Powder prepared from snake tissues for dipping in feet |
| 07/23/2003 | CN1430962A Skin liniment |
| 07/23/2003 | CN1430952A Asiaticoside liposome and its use |
| 07/23/2003 | CN1115167C Medical compsn. for treating leukoderma |
| 07/23/2003 | CN1115164C Medicinal lotion for treating skin disease |
| 07/23/2003 | CN1115148C Skin penetration enhancing components |
| 07/23/2003 | CN1115142C Deodorising powder |
| 07/23/2003 | CN1115141C In-situ generation of zinc pyrithione |
| 07/23/2003 | CN1115140C Cosmetics contg. brown grape and ginseng compsn. |
| 07/22/2003 | US6597004 Powdered far-infrared radiator and method of making the same |
| 07/22/2003 | US6596886 Method for producing a non-fatty softener based on wax-esters |
| 07/22/2003 | US6596867 Bone disorders |
| 07/22/2003 | US6596791 Polymer complexes of glucuronoglucanes |
| 07/22/2003 | US6596761 Cosmetic and dermatological preparation with flavonoids |
| 07/22/2003 | US6596753 Compounds of the indolecarboxylic family and use thereof |
| 07/22/2003 | US6596746 Cyclic protein tyrosine kinase inhibitors |
| 07/22/2003 | US6596738 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): |
| 07/22/2003 | US6596721 (6S)- or 10 (6R,S)- tetrahydrofolic acid is crystallized in a polar medium with pH of 3.5 or greater and have a purity 98% |
| 07/22/2003 | US6596704 Spraying, painting or squirting gellan gum composition on the wound or skin injury to form an immobile gel |
| 07/22/2003 | US6596695 Topical application of immixture of ascorbic acid + ascorbic acid compounds for augmenting the synthesis of epidermal ceramides |
| 07/22/2003 | US6596687 Cell adhesion inhibitors |
| 07/22/2003 | US6596491 Tenascin-C nucleic acid ligands |
| 07/22/2003 | US6596282 Treatment of chronic viral infections with M. vaccae |
| 07/22/2003 | CA2294422C Tartrate salt of a substituted dipeptide |
| 07/22/2003 | CA2245250C Benzofuran-acrylic acid derivatives and their use as modulators of rxrs or rars receptors |
| 07/22/2003 | CA2195185C Ascorbyl-phosphoryl-cholesterol |
| 07/21/2003 | CA2416791A1 A receptor-ligand pairing for immune response |
| 07/21/2003 | CA2368656A1 Receptor-ligand pairing for anti-inflammatory response |
| 07/17/2003 | WO2003057856A2 Dominant negative proteins and methods thereof |
| 07/17/2003 | WO2003057854A2 Novel proteins and nucleic acids encoding same |
| 07/17/2003 | WO2003057725A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 07/17/2003 | WO2003057707A1 2-o-( -d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 07/17/2003 | WO2003057700A1 Compositions containing pigmentatin inhibitor, use thereof and process for producing the same |
| 07/17/2003 | WO2003057696A1 Deazapurines and uses thereof |
| 07/17/2003 | WO2003057676A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 07/17/2003 | WO2003057673A1 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 07/17/2003 | WO2003057668A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
| 07/17/2003 | WO2003057666A2 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057252A1 Human mast cell-expressed membrane proteins |
| 07/17/2003 | WO2003057249A1 Combination treatments for allergic disease comprising administering an anti-ige antibody and antiallergic compound |
| 07/17/2003 | WO2003057246A1 Proteases producing an altered immunological response and methods of making and using the same |
| 07/17/2003 | WO2003057234A1 Topical cosmetic composition having a natural plant active ingredient and method of using same |
| 07/17/2003 | WO2003057228A1 Carbon dioxide compositions for external use and process for producing the same |
| 07/17/2003 | WO2003057219A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 07/17/2003 | WO2003057211A1 Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases. |
| 07/17/2003 | WO2003057210A1 Compositions and methods for increasing cell proliferation comprising a flavonoid |
| 07/17/2003 | WO2003057196A1 Drug mixture with enhanced dissolution rate |
| 07/17/2003 | WO2003057166A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 07/17/2003 | WO2003057152A2 Hair follicle growth |
| 07/17/2003 | WO2003057147A2 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 07/17/2003 | WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057141A2 Methods for improving the aesthetic appearance of skin |
| 07/17/2003 | WO2003057135A2 Aqueous compositions containing metronidazole |
| 07/17/2003 | WO2003057134A2 Specific binding agents of human angiopoietin-2 |
| 07/17/2003 | WO2003057133A2 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 07/17/2003 | WO2003020325A3 Methods for sterilizing preparations containing albumin |
| 07/17/2003 | WO2003011329A3 Vaccine for prophylaxis and therapy of dermatophytosis in veterinary and human medicine |
| 07/17/2003 | WO2003009810B1 Silver alginate foam compositions |
| 07/17/2003 | WO2003008410A3 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 07/17/2003 | WO2003000896A3 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |